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Abstract		Purpose	of	review:	Mortality	has	long	been	the	gold-standard	outcome	measure	for	intensive	care	clinical	trials.	However	as	the	critical	care	community	begins	to	understand	and	accept	that	survivorship	is	associated	with	functional	disability	and	 a	 health	 and	 socioeconomic	 burden,	 the	 clinical	 and	 research	 focus	 has	begun	to	shift	towards	long	term	physical	function	Recent	 findings:	 To	 use	 mortality	 as	 a	 primary	 outcome	 measure,	 one	 would	either	 have	 to	 choose	 an	 improbable	 effect	 (e.g.	 a	 difference	 of	 5-10%	 in	mortality	 as	 a	 result	 of	 a	 single	 intervention)	 or	 recruit	 a	 larger	 number	 of	patients;	the	latter	being	unfeasible	for	most	critical	care	trials.	Outcome	measures	will	need	to	match	interventions.	As	an	example,	amino	acids,	or	 intermittent	 feeding	 can	 stimulate	 muscle	 protein	 synthesis,	 and	 so	prevention	of	muscle	wasting	may	seem	an	appropriate	outcome	measure	when	assessing	 the	 effectiveness	 of	 these	 interventions.	 Testing	 the	 effectiveness	 of	these	 interventions	 requires	 the	 development	of	 novel	outcome	measures	 that	are	 targeted	 and	 acceptable	 to	 patients.	 	 We	 describe	 advancements	 in	 DXA	scanning,	 bio-impedence	 analysis,	 MRI,	 and	 muscle	 ultrasound	 in	 this	 patient	group	that	are	beginning	to	address	this	development	need.			Summary:	New	approaches	 to	outcome	assessment	are	beginning	 to	appear	 in	post-ICU	research	which	promise	to	improve	our	understanding	of	nutrition	and	exercise	 interventions	 on	 skeletal	muscle	 structure,	 composition,	 and	 function,	without	causing	undue	suffering	to	the	patient.		
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Introduction	Mortality	has	 long	been	 the	gold-standard	outcome	measure	 for	 intensive	 care	clinical	 trials	 -	 this	 being	 the	 ultimate	 rationale	 behind	 the	 use	 of	multi-organ	support	 in	 the	 sickest	 patients	 [1].	 However,	 hospital	 and	 Intensive	 Care	mortality	are	perhaps	no	longer	considered	the	best	time	points,	with	90-day,	6-month	 and	 1-year	 mortality	 being	 examined	 [2].	 Additionally,	 acquired	morbidity	following	critical	illness	is	of	increasing	interest[3].	This	changing	 face	of	 intensive	care	medicine	has	ramifications	 for	clinical	 trial	design	and	methodology,	including	trials	investigating	nutrition	interventions.	In	the	setting	of	modern	critical	care,	an	unrefined	patient	population	will	have	an	in	intensive	care	unit	(ICU)	mortality	of	20%,	rising	to	closer	to	30%	at	hospital	discharge[4].		To	use	mortality	as	a	primary	outcome	measure,	one	would	either	have	to	choose	an	improbable	effect	(e.g.	a	difference	of	5-10%	in	mortality	as	a	result	of	a	single	intervention)	or	recruit	a	larger	number	of	patients;	the	latter	being	unfeasible	 for	most	critical	care	trials[5].	However,	equipoise	exists	as	 to	whether	or	not	a	single	 intervention	can	affect	mortality	 in	a	population	where	multiple	physiological	stressors	(e.g.	inflammation,	hypoxia,	multi-organ	failure)	will	 contribute.	 This	 scenario	 is	 possibly	 fuelled	 by	 large	 multi-centre	observational	 studies	 demonstrating	 positive	 associations	 between	 single	interventions,	 such	as	nutritional	delivery[6].	However,	 the	 recently	 completed	TARGET	 study	 (NCT02306746.	 The	 Augmented	 versus	 Routine	 approach	 to	
Giving	Energy	Trial)	did	 indeed	 recruit	 a	 large	number	of	patients	 (4000)	and	may	offer	a	potential	answer	on	causality.		As	 a	 result	 of	 the	 growing	 interest	 in	 survivorship,	 critical	 care	 trials	 are	increasingly	 either	 embedding	 health	 related	 quality	 of	 life	 and/or	 functional	outcome	measures	as	secondary	outcomes,	or	using	these	measures	as	primary	outcomes[7,	 8].	 Considering	 these	 outcomes,	 nutritional	 interventions	 are	plausible	as	appropriate,	 effective	 interventions.	Amino	acid	availability	affects	protein	homeostasis	and	thus	muscle	mass.	Substrates	for	energy	production	are	necessary	 for	 protein	 homeostasis	 and	 for	 muscle	 (and	 indeed	 all	 cells)	 to	
function[9].	 Thus,	 nutritional	 interventions	 may	 indeed	 affect	 functional	 and	health	related	outcomes	by	affecting	muscle	mass	and	function,	but	limited	data	exist	to	support	this.				
Signal-to-noise	ratios	Several	recent	trials	have	incorporated	measures	of	muscle	mass	or	physical	or	functional	 outcomes	 into	 their	 study	 design,	 albeit	 mainly	 as	 secondary	outcomes	or	in	smaller	sub-studies,	with	varying	results	[10-12].		As	an	example,	EAT-ICU[11]	 aimed	 to	 investigate	 the	 effect	 of	 early	 goal	 directed	 nutrition	(EGDN)	over	the	first	week	of	ICU	stay	on	the	Physical	Component	Score	(PCS)	of	the	SF-36	 survey	at	6	months.	Protein	 intakes	were	 targeted	 based	on	urinary	urea	 nitrogen	 measurements	 and	 adjusted	 according	 to	 plasma	 urea.	 No	differences	in	the	primary	or	secondary	outcomes	were	found.		Such	studies	lead	clinicians	 to	 believe	 that	 nutrition	 support	 does	 not	 enhance	 physical	 or	functional	outcomes.	This	may	or	not	be	true,	but	it	is	not	clear	that	such	studies	(no	 matter	 how	 well	 executed)	 contribute	 to	 this	 understanding.	 Long	 term	outcomes	are	affected	by	a	multitude	of	factors	preceding	critical	illness	(such	as	frailty,	co-morbidities	and	socio-economic	status),	and	post	critical	illness	(such	as	 persistent	 inflammation,	 new	 organ	 dysfunction	 and	 post-traumatic	 stress	disorders)[13].	To	statistically	dissect	out	the	signal	of	a	5	or	10	day	intervention	on	6-month	to	1-year	outcomes	through	this	noise	would	seem	challenging	if	not	nearly	impossible,	regardless	of	the	intervention[14].	Several	post-hoc	analyses	of	 physical	 rehabilitation	 trials	 have	 demonstrated	 the	 importance	 of	 baseline	correction	for	outcome	[15]	and	stratification	by	post-critical	illness	biology[16]	as	methods	to	refine	data	for	outcome	analyses.		Two	newer	concepts	are	likely	to	be	explored	in	future	critical	care	trials.	First,	“critical	 illness”	 is	 currently	 being	 defined	 by	 time	 epochs	 -	 “acute	 critical	illness”,	 “chronic	 critical	 illness[17]”,	 and	 “post-intensive	 care	 syndrome[18]”.	However,	 these	 epochs	 lack	 markers	 of	 division	 where	 these	 markers	 are	 far	more	 likely	 to	 be	 biological	 as	 opposed	 to	merely	 time	 based	 (e.g.	markers	 of	inflammation	versus	 days	 since	admission).	This	 is	particularly	pertinent	when	considering	 trials	 of	 nutrition	 and	 exercise	 where	 the	 biological	 interaction	
between	these	 interventions	may	be	uncoupled	early	 in	critical	 illness[19],	and	are	likely	to	only	be	effective	once	this	is	recoupled[20].	Work	has	begun	within	the	epoch	between	ICU	discharge	and	hospital	discharge,	an	area	with	little	data	and	where	interventions	are	far	more	likely	to	be	effective	as	the	confounders	of	inflammation,	hypoxia	and	multi-organ	failure	have	subsided	[21,	22].	We	now	know	 that,	 post	 discharge,	 our	 patients	 continue	 through	 their	 hospital	admission	not	meeting	energy	or	protein	 targets	 [23]	which	 is	 likely	 to	have	a	significant	impact	on	outcome	and	needs	to	be	accounted	for.				Second,	 outcome	 measures	 will	 need	 to	 match	 interventions.	 As	 an	 example,	amino	acids,	or	intermittent	feeding	can	stimulate	muscle	protein	synthesis,	and	so	 prevention	 of	 muscle	 wasting	 may	 seem	 an	 appropriate	 outcome	measure	when	assessing	the	effectiveness	of	these	interventions.	For	muscle	to	gain	mass	and	quality	(and	therefore	increase	function)	a	combination	of	amino	acids	and	exercise	are	 required.	A	 functional	outcome	may	 therefore	be	appropriate[24].	The	difficulty	here	 is	 that	 this	 is	 an	emerging	aspect	of	 critical	 care	nutritional	research,	 and	 therefore	 knowledge	 translation	 from	 other	 patient	 groups	 are	necessary.	
	
Understanding	metabolic	 dysfunction	 is	 essential	 for	 successful	 outcome	
development		Much	 work	 has	 been	 done	 in	 understanding	 the	 unique	 factors	 underpinning	measurement	 instruments	 of	 physical	 function	 in	 trials	 of	 rehabilitation	 in	critical	 illness.[25]	An	 important	element	that	has	come	out	of	 this	work	 is	 the	importance	 of	 considering	 an	 instrument	 that	 matches	 the	 intended	 outcome	and	the	intervention.	Much	less	work	has	been	done	in	the	field	of	nutrition	and	whilst	 the	 importance	 of	 including	 physical	 or	 functional	 outcomes	 in	 trials	of	nutrition	support	in	critical	illness	is	accepted,	much	less	is	understood	about	the	underlying	physiology	of	 these	 interventions	how	 they	will	 lead	 to	 the	desired	outcome.[26]	 It	 is	 likely	 that	 different	 interventions,	 and	 therefore	 perhaps	outcome	measures,	will	be	most	useful	at	different	time	epochs	during	admission	to	match	the	dynamic	changes	in	physiology	(figure	1).	
	Starting	 from	 admission,	 baseline	 characteristics	 play	 an	 important	 role	 in	 the	likelihood	 of	 a	 successful	 intervention.	 Patients	 may	 enter	 the	 ICU	malnourished[27]	or	with	low	muscle	mass[28],	with	several	co-morbities	or	of	an	 advanced	 age;	 all	 of	 which	 not	 only	 influence	 functional	 performance	 and	ability[7,	 29],	 but	 response	 to	 nutrition.[30]	 The	 amount	 of	muscle	mass	may	influence	requirements	for	nutrients	such	as	protein,	however,	current	practice	is	 to	 set	 targets	 based	 on	 bodyweight	 (actual	 or	 ideal)	 as	 opposed	 to	 body	composition	 (e.g.	 amount	 of	 lean	 mass).	 It	 would	 not	 seem	 unreasonable	 to	suggest	 that	 nutrition	 targets	 should	 be	 based	 on	 the	 amount	 muscle	 mass	 if	functional	outcomes	are	to	be	measured.			Throughout	 the	 first	week	 of	 ICU	 stay	 it	 has	 been	 shown	 that	muscle	 protein	synthesis	 is	 initially	 depressed	 to	 levels	 associated	 with	 fasted	 controls,	 with	variable	recovery	over	the	 following	seven	days,	but	muscle	protein	catabolism	remains	 raised	 leading	 to	 a	 net	 catabolic	 balance	 and	 the	 subsequent	 loss	 of	skeletal	 muscle.[31]	 New	 data	 suggests	 that	 that	 muscle	 protein	 balance	becomes	less	negative	over	time,	with	a	plateau	at	about	day	35[32]	Importantly,	driven	mainly	by	an	increase	in	muscle	protein	synthesis.	These	data	support	the	suggestion	 that	 nutrition	 interventions	 should	 be	 tailored	 to	 the	 time	 point	 of	admission	 according	 to	 the	 physiological	 changes	 that	 are	 occurring.	 For	example,	 specific	 amino	 acid	metabolites,	 such	 as	b-hydroxy-b-methylbutyrate	(HMB)	 which	 target	 catabolic	 pathways	 [33],	 may	 be	 efficacious	 in	 the	 early	phases	of	ICU	admission.	This	may	be	followed	by	administration	of	amino	acids	such	as	Leucine,	that	target	the	pathways	of	muscle	protein	synthesis[34],	in	the	latter	phases	of	critical	illness	to	tip	the	balance	into	a	more	anabolic	state.		Underpinning	all	of	the	above	is	the	contribution	of	inflammation	and	generation	of	 Adenosine	 TriPhosphate	 (ATP).	 Both	 inflammation	 and	 lack	 of	 ATP	 inhibit	muscle	 protein	 synthesis	 which	 may	 be	 a	 limiting	 factor	 for	 any	 intervention	aiming	 to	 reduce	 skeletal	muscle	wasting	 and	 enhance	 physical	 and	 functional	performance[35].	Considering	nutrition	interventions	that	modulate	these,	such	as	 HMB	 or	 inducing	 ketosis	 to	 provide	 an	 alternative	 fuel	 source	 for	 ATP	generation,	may	be	warranted[9]	.	
	Lastly,	the	combined	effect	of	nutrition	and	exercise	requires	consideration[36],	though	 implementation	 of	 this	 strategy	 is	 not	 without	 difficulty	 as	 there	 are	several	 factors	 which	 may	 influence	 functional	 ability	 including	 muscle	endurance,	 fatigability,	 cognition,	 mental	 health,	 sleep	 disturbance	 along	 with	the	 patients’	 pre-morbid	 health,	 age	 and	 length	 of	 illness[7,	 25,	 29].	 Nutrition	strategies	 to	 combine	 with	 different	 exercise	 regimens	 require	 careful	consideration	 of	 the	 mechanisms	 underlying	 their	 potential	 effect.	 Data	 from	populations	 outside	 of	 critical	 illness	 may	 provide	 important	 insights.	 For	example,	 coupling	 exercise	 with	 bolus	 /	 intermittent	 feeding	 to	 enhance	 the	anabolic	window	seen	with	the	‘muscle	full	effect’	in	healthy	individuals	may	be	one	intervention	worth	considering.				
Muscle	mass	based	outcome	measures	in	the	critical	illness	survivor		Although	 our	 understanding	 of	 the	 physical	 problems	 faced	 by	 ICU	 survivors	continues	to	increase,	the	gulf	in	the	literature	between	what	happens	to	skeletal	muscle	 during	 and	 after	 acute	 critical	 illness	 is	 significant.	 	 Whilst	 critically	unwell,	 patients	 remain	 within	 convenient	 proximity	 of	 the	 researchers,	 and	unpleasant	 procedures	 such	 as	muscle	 biopsy	 can	 be	 conducted	under	 analgo-sedation	 or	 anaesthesia,	 lessening	 the	 inconvenience	 and	 discomfort	experienced	by	the	 individual.	 	Once	discharged	to	the	community,	 follow	up	 is	far	 less	 complete[37].	 Our	 understanding	 of	 what	 happens	 to	 skeletal	 muscle	after	hospital	discharge	is	often	derived	indirectly	from	outcome	measures	that	can	be	assessed	reliably	by	telephone	interview	or	survey	as	seen	in	the	recent	EAT-ICU	trial[11].				It	 is	 in	 smaller	 scale	 observational	 studies	 exploring	 the	 mechanisms	 of	weakness	and	recovery	that	the	more	proximal	and	organ-specific	measures	can	be	 found..	 Even	 blood	 sampling	 suffers	 significantly	 greater	 attrition	 when	compared	 to	 other	 outcome	measures[16].	 It	 seems	 unlikely	 that	 participants	who	 feel	 able	 to	 return	 to	 a	 healthcare	 facility	 for	 detailed	 testing	 are	 truly	
representative	 of	 a	 population	 that	 may	 also	 contain	 individuals	 who,	 for	physical	or	psychological	reasons,	can’t	attend.		Unfortunately,	our	most	detailed	studies	 of	 muscular	 regeneration	 after	 ICU	 may	 have	 so	 far	 mainly	 been	conducted	 in	 the	 fittest	 of	 ICU	 survivors.	 New	 approaches	 to	 outcome	assessment	 are	 beginning	 to	 appear	 in	 post-ICU	 research	 which	 promise	 to	improve	 our	 understanding	of	 nutrition	 and	 exercise	 interventions	 on	 skeletal	muscle	structure,	composition,	and	function,	without	causing	undue	suffering	to	the	patient.				In	 the	sub-study	of	patients	with	ARDS	 	mentioned	above,	Chan	and	colleagues	employed	Dual	 energy	 x-ray	 absorptiometry	 (DXA)	 to	 study	 body	 composition	after	ICU	discharge,	participants	tended	to	gain	fat	mass	whilst	maintaining	lean	(skeletal	muscle)	mass.	 	Although	strength	and	self-reported	 function	were	not	affected	 by	 body	 composition,	 walking	 speed	 and	 distance	 were	 improved	 in	patients	 that	 had	 a	 higher	muscle	 to	 fat	 ratio,	 perhaps	 revealing	 an	 important	link	between	body	composition	and	physical	function[38].				As	 a	 nutrition	 outcome	 measure,	 DXA	 scanning	 is	 therefore	 appealing.	 	 It	 is	acceptable	 to	 patients,	 is	 conducted	with	 a	 very	 low	dose	 of	 ionizing	 radiation	and	provides	information	about	both	fat	and	muscle	mass.		This	latter	benefit	is	particularly	relevant	to	studies	of	nutrition	interventions	where	improvement	of	lean	mass,	in	specific	preference	to	an	increase	in	fat	mass,	is	often	the	goal.		A	continuous	improvement	 in	 the	portability	and	resolution	of	musculoskeletal	ultrasound	(US)	make	it	attractive	as	a	non-invasive	measure	of	muscle	volume	and	 quality	 during	 follow	 up	 from	 ICU,	 and	 may	 be	 the	 ideal	 modality	 for	assessing	the	 impact	of	nutrition	 interventions	during	and	after	 ICU	admission.			Measurements	 of	 muscle	 mass,	 quality	 and	 architectural	 structure	 have	 been	embraced[39]..	 	 Despite	 a	 significant	 variation	 in	 the	 conduct	 and	 reporting	 of	these	studies,	and	a	requirement	for	standardisation	of	approaches[40,	41],	the	emergence	of	novel	ultrasound	measures,	such	as	measures	of	glycogen	storage,	may	 have	 relevance	 in	 the	 post-ICU	 period,	 despite	 having	 limitations	 in	 the	acutely	unwell	patient.		Surprisingly,	the	application	of	musculoskeletal	US	in	the	post-ICU	 period	 has	 been	 limited.	 	 In	 a	 37	 patient	 study	 of	 ICU	 patients	 with	
traumatic	 brain	 injury	 (TBI),	 quadriceps	 muscle	 layer	 thickness	 (QMLT)	 was	assessed	 in	 the	 post-ICU	 ward	 after	 ICU	 discharge	 and	 at	 3	 months	 post-ICU	discharge.		Eight	of	the	included	patients	underwent	DXA	scanning	and	in	these	patients,	 total	 body	 lean	mass	was	 strongly	 associated	with	 QMLT,	 suggesting	perhaps	 a	 role	 for	 post-ICU	US	 for	 assessment	 of	muscle	 quality.	 	 Despite	 this,	like	many	other	post-ICU	studies,	there	was	major	attrition,	with	only	13	(35%)	of	the	original	sample	available	for	US	at	3	months[27].		Body	 composition	 can	 be	 also	 estimated	 non-invasively	 using	 	 bioelectrical	impedance	(BIA).	In	healthy	individuals,	BIA	can	reliably	estimate	fat	free	mass	(FFM)	 by	 applying	 regression	 equations	 to	 measured	 BIA	 parameters.	 	 These	estimates	 are	 not	 accurate	 in	 patients	 with	 deranged	 physiology,	 where	 fluid	compartments	 are	 dynamic	 such	 as	 in	 critical	 illness[42].	 Raw	 values	 such	 as	phase	angle	may	be	useful	 for	predicting	outcome	in	certain	disease	states,	but	for	tracking	nutrition	during	critical	illness	are	unlikely	to	be	useful,	as	changes	may	 reflect	 alterations	 in	 fluid	 status	rather	 than	nutrition	or	muscle	mass.	 	 In	the	post-ICU	period,	there	may	be	value	in	studying	phase	angle	over	time	and	if	validated	against	a	radiological	measure	such	as	intramuscular	fat	fraction,	may	have	significant	value	as	a	marker	of	nutrition	recovery.		Measurements	of	muscle	 cross	 sectional	 area	and	density,	 reflecting	 total	body	muscle	 mass	 and	 quality,	 have	 been	 measured	 in	 diagnostic	 computed	tomography	 (CT)	 scans	 acquired	 during	 critical	 illness[39].	 Low	 muscle	 mass	and	quality	are	associated	with	negative	outcomes,	such	as	mortality	and	length	of	ICU	treatment[39,	43]	but	even	in	the	hospital	setting,	the	drawbacks	of	cost,	time,	 transport	 risk	 and	 radiation	 exposure	 preclude	 prospective	 evaluation.		Although	 the	 transport	 risks	 in	 the	 post-ICU	 patient	 are	 minimal,	 the	 other	drawbacks	 remain	 significant	 and	 CT	 has	 not	 yet	 been	 used	 to	 track	 muscle	recovery	after	hospital	discharge.	However,	given	the	use	of	CT	to	diagnose	and	monitor	a	significant	number	of	other	factors	which	influence	patient	morbidity,	it	 is	 perhaps	 not	 unreasonable	 to	 begin	 to	 consider	 the	 use	 of	 in-hospital	 CT	scans	 to	monitor	 body	 composition	 and	 allow	 treatments	 to	 be	 tailored	 to	 the	individual.		
Similarly,	magnetic	resonance	 imaging	(MRI)	provides	an	alternative	to	muscle	biopsy	in	the	study	of	myopathy.		In	contrast	to	radiological	techniques,	MRI	can	identify	muscle	abnormalities	within	 specific	muscle	 compartments	 identifying	areas	 of	 oedema	 (normally	 associated	 with	 acute	 processes),	 and	 lipid	infiltration	(normally	associated	with	chronic	process).		It	will	also	undoubtedly	be	useful	for	delineating	the	precise	location	of	fat	(intra-	versus	extra-muscular)	in	body	composition	studies.			Although	impractical	in	the	assessment	of	acutely	unwell	patients,	it’s	feasibility	in	the	post-ICU	period	is	currently	being	explored		(Griffith	 personal	 communication;	 trial	 registry	 ISCTRN1782997).	Whilst	 likely	to	be	useful	in	exploring	mechanisms	of	muscular	recovery,	its	importance	as	an	outcome	measure	in	ICU	nutrition	trials	is	currently	limited	by	its	cost,	and	the	unclear	 relationship	 to	 physical	 outcomes.	 	 Further	 research	 is	 required	 to	understand	 whether	 a	 reduction	 in	 oedema	 or	 an	 improvement	 in	 muscle	quality,	translate	into	an	improvement	in	health.		
Conclusion		Nutritional	 research	 in	 critical	 illness	 continues	 to	 evolve.	 To	maintain	 clinical	relevance,	outcome	measures	related	to	 function	and	muscle	mass	are	 likely	 to	be	increasingly	important	as	opposed	to	mortality.	Newer	outcomes	are	needed	that	map	to	the	increasingly	diverse	and	complex	interventions	seen	in	trials.		Summary	points	1.	 The	 focus	 of	 critical	 care	 research	 is	 shifting	 from	 survival	 to	 long	 term	physical	function	2.	 Innovative	 nutrition	 interventions	 are	 likely	 to	 have	 a	 pivotal	 role	 in	maintaining	 neuromuscular	 function	 during	 critical	 illness	 and	 restoring	 it	afterwards.	3.	Testing	 the	effectiveness	of	 these	 interventions	 requires	 the	development	of	novel	outcome	measures	that	are	targeted	and	acceptable	to	patients.			4.	We	describe	advancements	in	DXA	scanning,	bio-impedence	analysis,	MRI,	and	muscle	 ultrasound	 in	 this	 patient	 group	 that	 are	 beginning	 to	 address	 this	development	need.				
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Figure	1:	Potential	outcome	measures	and	considerations	which	may	influence	outcome	 at	 each	 time	 point	 during	 critical	 illness.CT,	 Computed	 Tomography;	BIA,	Bioelectrical	Impedance	Analysis;	DXA,	Dual	energy	x-ray	absorptiometry				
